NASDAQ : ARTL
Artelo Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.22 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 7.25M | 5.98M | 4.12M | 4.23M | 5.96M | 6.29M |
| Research & Development | 3.82M | 5.42M | 5.99M | 5.70M | 4.32M | 5.83M |
| Operating Expenses | 11.07M | 11.40M | 10.11M | 9.93M | 10.29M | 12.13M |
| Operating Income | -11.07M | -11.40M | -10.11M | -9.93M | -10.29M | -12.13M |
| Interest Expense | -335.00K | -277.00K | -5.00K | |||
| Interest & Investment Income | 35.00K | 2.00K | 3.00K | |||
| Other Non Operating Income (Expenses) | -208.00K | -62.00K | ||||
| EBT Excluding Unusual Items | -11.58M | -11.74M | -10.11M | -9.93M | -10.29M | -12.12M |
| Gain (Loss) on Sale of Investments | 22.00K | 22.00K | 282.00K | 641.00K | 207.00K | 18.00K |
| Other Unusual Items | -1.12M | -1.16M | ||||
| Pretax Income | -12.67M | -12.88M | -9.83M | -9.29M | -10.08M | -12.11M |
| Net Income | -12.67M | -12.88M | -9.83M | -9.29M | -10.08M | -12.11M |
| Net Income to Common | -12.67M | -12.88M | -9.83M | -9.29M | -10.08M | -12.11M |
| Shares Outstanding (Basic) | 123.72K | 38.11K | 19.89K | 18.27K | 17.49K | 13.77K |
| Shares Outstanding (Diluted) | 123.72K | 38.11K | 19.89K | 18.27K | 17.49K | 13.77K |
| EPS (Basic) | -102.42 | -337.93 | -494.04 | -508.37 | -576.57 | -879.40 |
| EPS (Diluted) | -102.42 | -337.93 | -494.04 | -508.37 | -576.57 | -879.66 |
| Free Cash Flow | -12.63M | -8.52M | -8.35M | -8.21M | -8.01M | -8.00M |
| Free Cash Flow Per Share | -102.11 | -223.56 | -419.83 | -449.16 | -457.91 | -581.26 |
| EBIT | -11.07M | -11.40M | -10.11M | -9.93M | -10.29M | -12.13M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.20M | 600.00K | 2.34M | 2.81M | 6.89M | 12.16M |
| Short-Term Investments | 1.50M | |||||
| Trading Asset Securities | 7.61M | 9.15M | 11.95M | |||
| Cash & Short-Term Investments | 4.20M | 600.00K | 2.34M | 10.43M | 17.53M | 24.11M |
| Prepaid Expenses | 173.00K | 95.00K | 219.00K | 554.00K | 789.00K | 496.00K |
| Total Current Assets | 4.37M | 695.00K | 2.56M | 10.98M | 18.32M | 24.61M |
| Property, Plant & Equipment | 46.00K | 64.00K | 99.00K | 21.00K | 60.00K | 81.00K |
| Long-Term Investments | 1.52M | |||||
| Other Intangible Assets | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Other Long-Term Assets | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Assets | 6.46M | 2.80M | 4.70M | 13.04M | 20.42M | 28.25M |
| Accounts Payable | 1.30M | 3.04M | 1.68M | 1.24M | 905.00K | 975.00K |
| Accrued Expenses | 111.00K | 359.00K | 61.00K | 30.00K | 53.00K | 21.00K |
| Short-Term Debt | 609.00K | |||||
| Current Portion of Leases | 42.00K | 40.00K | 35.00K | 23.00K | 40.00K | 31.00K |
| Other Current Liabilities | 1.00K | |||||
| Total Current Liabilities | 1.46M | 4.04M | 1.77M | 1.29M | 998.00K | 1.03M |
| Long-Term Leases | 7.00K | 29.00K | 69.00K | 23.00K | 57.00K | |
| Total Liabilities | 1.46M | 4.07M | 1.84M | 1.29M | 1.02M | 1.08M |
| Common Stock | 4.00K | 2.00K | 1.00K | 3.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 73.64M | 62.01M | 53.19M | 52.26M | 50.67M | 48.12M |
| Retained Earnings | -68.40M | -63.02M | -50.14M | -40.31M | -31.02M | -20.94M |
| Comprehensive Income & Other | -242.00K | -272.00K | -202.00K | -203.00K | -254.00K | -18.00K |
| Shareholders' Equity | 5.00M | -1.27M | 2.86M | 11.75M | 19.40M | 27.17M |
| Total Liabilities & Equity | 6.46M | 2.80M | 4.70M | 13.04M | 20.42M | 28.25M |
| Total Debt | 49.00K | 678.00K | 104.00K | 23.00K | 63.00K | 88.00K |
| Net Cash (Debt) | 4.15M | -78.00K | 2.23M | 10.40M | 17.47M | 24.02M |
| Net Cash Per Share | 33.53 | -2.05 | 112.32 | 569.34 | 998.97 | 1,745.37 |
| Filing Date Shares Outstanding | 510.56K | 78.69K | 20.25K | 19.92K | 17.63K | 17.41K |
| Total Common Shares Outstanding | 465.38K | 74.77K | 20.25K | 19.68K | 17.63K | 17.41K |
| Working Capital | 2.92M | -3.35M | 785.00K | 9.69M | 17.32M | 23.58M |
| Book Value Per Share | 10.74 | -17.01 | 141.07 | 597.00 | 1,100.69 | 1,560.60 |
| Tangible Book Value | 2.96M | -3.31M | 818.00K | 9.71M | 17.36M | 25.13M |
| Tangible Book Value Per Share | 6.36 | -44.28 | 40.39 | 493.42 | 985.02 | 1,443.47 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.67M | -12.88M | -9.83M | -9.29M | -10.08M | -12.11M |
| Other Amortization | 262.00K | 208.00K | ||||
| Loss (Gain) From Sale of Investments | -282.00K | -641.00K | -207.00K | -18.00K | ||
| Stock-Based Compensation | 1.77M | 1.14M | 818.00K | 1.02M | 2.46M | 2.80M |
| Other Operating Activities | 1.36M | 1.25M | 33.00K | 40.00K | 39.00K | 30.00K |
| Change in Accounts Payable | -3.38M | 1.59M | 480.00K | 273.00K | 23.00K | 1.50M |
| Change in Other Net Operating Assets | 29.00K | 163.00K | 427.00K | 390.00K | -238.00K | -210.00K |
| Operating Cash Flow | -12.63M | -8.52M | -8.35M | -8.21M | -8.01M | -8.00M |
| Investment in Securities | 7.77M | 3.51M | 2.96M | -30.10M | ||
| Other Investing Activities | -62.00K | -62.00K | ||||
| Investing Cash Flow | -62.00K | -62.00K | 7.77M | 3.51M | 2.96M | -30.10M |
| Short-Term Debt Issued | 608.00K | |||||
| Total Debt Issued | 464.00K | 608.00K | ||||
| Short-Term Debt Repaid | -24.00K | |||||
| Total Debt Repaid | -1.27M | -24.00K | -3.00K | |||
| Net Debt Issued (Repaid) | -802.00K | 584.00K | -3.00K | |||
| Issuance of Common Stock | 15.65M | 6.28M | 112.00K | 567.00K | 54.79M | |
| Financing Cash Flow | 14.85M | 6.87M | 112.00K | 567.00K | 54.78M | |
| Foreign Exchange Rate Adjustments | -20.00K | -23.00K | -8.00K | 60.00K | -224.00K | -84.00K |
| Net Cash Flow | 2.13M | -1.74M | -477.00K | -4.07M | -5.27M | 16.60M |
| Free Cash Flow | -12.63M | -8.52M | -8.35M | -8.21M | -8.01M | -8.00M |
| Free Cash Flow Per Share | -102.11 | -223.56 | -419.83 | -449.16 | -457.91 | -581.26 |
| Levered Free Cash Flow | -8.57M | -4.17M | -4.70M | -4.64M | -4.31M | |
| Unlevered Free Cash Flow | -8.63M | -4.20M | -4.70M | -4.64M | -4.30M | |
| Change in Working Capital | -3.35M | 1.75M | 907.00K | 663.00K | -215.00K | 1.29M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.22M | 2.46M | 3.42M | 4.46M | 8.25M | 21.95M |
| Enterprise Value | -2.93M | 1.70M | -1.32M | -8.37M | -11.16M | 11.98M |
| Last Close Price | 2.22 | 32.94 | 171.72 | 226.80 | 468.18 | 1,261.17 |
| PB Ratio | 0.21 | -1.94 | 1.20 | 0.38 | 0.42 | 0.81 |
| P/TBV Ratio | 0.41 | 4.18 | 0.46 | 0.47 | 0.87 | |
| Debt / Equity Ratio | 0.01 | -0.53 | 0.04 | 0.00 | 0.00 | 0.00 |
| Net Debt / Equity Ratio | -0.83 | -0.06 | -0.78 | -0.89 | -0.90 | -0.88 |
| Net Debt / FCF Ratio | 0.33 | -0.01 | 0.27 | 1.27 | 2.18 | 3.00 |
| Quick Ratio | 2.88 | 0.15 | 1.32 | 8.08 | 17.57 | 23.48 |
| Current Ratio | 3.00 | 0.17 | 1.44 | 8.51 | 18.36 | 23.96 |
| Return on Equity (ROE) | -705.71% | -1,625.11% | -134.52% | -59.63% | -43.30% | |
| Return on Assets (ROA) | -127.92% | -190.09% | -71.22% | -37.09% | -26.42% | |
| Return on Capital Employed (ROCE) | -221.20% | 917.50% | -345.50% | -84.50% | -53.00% | -44.50% |
| Earnings Yield | -4,613.29% | -522.93% | -287.20% | -208.07% | -122.18% | -55.14% |
| FCF Yield | -1,038.85% | -345.94% | -244.06% | -183.83% | -97.04% | -36.45% |
| Buyback Yield / Dilution | -502.96% | -91.62% | -8.85% | -4.48% | -27.05% |